Global Long-acting Hormone Injection Market Growth 2024-2030
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Long-acting Hormone Injection Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Long-acting Hormone Injection by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Long-acting Hormone Injection by Country/Region, 2019, 2023 & 2030 2.2 Long-acting Hormone Injection Segment by Type 2.2.1 Long-acting Contraceptive Injection 2.2.2 Growth Hormone Injection 2.2.3 Others 2.3 Long-acting Hormone Injection Sales by Type 2.3.1 Global Long-acting Hormone Injection Sales Market Share by Type (2019-2024) 2.3.2 Global Long-acting Hormone Injection Revenue and Market Share by Type (2019-2024) 2.3.3 Global Long-acting Hormone Injection Sale Price by Type (2019-2024) 2.4 Long-acting Hormone Injection Segment by Application 2.4.1 Hospital 2.4.2 Clinic 2.4.3 Others 2.5 Long-acting Hormone Injection Sales by Application 2.5.1 Global Long-acting Hormone Injection Sale Market Share by Application (2019-2024) 2.5.2 Global Long-acting Hormone Injection Revenue and Market Share by Application (2019-2024) 2.5.3 Global Long-acting Hormone Injection Sale Price by Application (2019-2024) 3 Global by Company 3.1 Global Long-acting Hormone Injection Breakdown Data by Company 3.1.1 Global Long-acting Hormone Injection Annual Sales by Company (2019-2024) 3.1.2 Global Long-acting Hormone Injection Sales Market Share by Company (2019-2024) 3.2 Global Long-acting Hormone Injection Annual Revenue by Company (2019-2024) 3.2.1 Global Long-acting Hormone Injection Revenue by Company (2019-2024) 3.2.2 Global Long-acting Hormone Injection Revenue Market Share by Company (2019-2024) 3.3 Global Long-acting Hormone Injection Sale Price by Company 3.4 Key Manufacturers Long-acting Hormone Injection Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Long-acting Hormone Injection Product Location Distribution 3.4.2 Players Long-acting Hormone Injection Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Long-acting Hormone Injection by Geographic Region 4.1 World Historic Long-acting Hormone Injection Market Size by Geographic Region (2019-2024) 4.1.1 Global Long-acting Hormone Injection Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Long-acting Hormone Injection Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Long-acting Hormone Injection Market Size by Country/Region (2019-2024) 4.2.1 Global Long-acting Hormone Injection Annual Sales by Country/Region (2019-2024) 4.2.2 Global Long-acting Hormone Injection Annual Revenue by Country/Region (2019-2024) 4.3 Americas Long-acting Hormone Injection Sales Growth 4.4 APAC Long-acting Hormone Injection Sales Growth 4.5 Europe Long-acting Hormone Injection Sales Growth 4.6 Middle East & Africa Long-acting Hormone Injection Sales Growth 5 Americas 5.1 Americas Long-acting Hormone Injection Sales by Country 5.1.1 Americas Long-acting Hormone Injection Sales by Country (2019-2024) 5.1.2 Americas Long-acting Hormone Injection Revenue by Country (2019-2024) 5.2 Americas Long-acting Hormone Injection Sales by Type (2019-2024) 5.3 Americas Long-acting Hormone Injection Sales by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Long-acting Hormone Injection Sales by Region 6.1.1 APAC Long-acting Hormone Injection Sales by Region (2019-2024) 6.1.2 APAC Long-acting Hormone Injection Revenue by Region (2019-2024) 6.2 APAC Long-acting Hormone Injection Sales by Type (2019-2024) 6.3 APAC Long-acting Hormone Injection Sales by Application (2019-2024) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Long-acting Hormone Injection by Country 7.1.1 Europe Long-acting Hormone Injection Sales by Country (2019-2024) 7.1.2 Europe Long-acting Hormone Injection Revenue by Country (2019-2024) 7.2 Europe Long-acting Hormone Injection Sales by Type (2019-2024) 7.3 Europe Long-acting Hormone Injection Sales by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Long-acting Hormone Injection by Country 8.1.1 Middle East & Africa Long-acting Hormone Injection Sales by Country (2019-2024) 8.1.2 Middle East & Africa Long-acting Hormone Injection Revenue by Country (2019-2024) 8.2 Middle East & Africa Long-acting Hormone Injection Sales by Type (2019-2024) 8.3 Middle East & Africa Long-acting Hormone Injection Sales by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Long-acting Hormone Injection 10.3 Manufacturing Process Analysis of Long-acting Hormone Injection 10.4 Industry Chain Structure of Long-acting Hormone Injection 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Long-acting Hormone Injection Distributors 11.3 Long-acting Hormone Injection Customer 12 World Forecast Review for Long-acting Hormone Injection by Geographic Region 12.1 Global Long-acting Hormone Injection Market Size Forecast by Region 12.1.1 Global Long-acting Hormone Injection Forecast by Region (2025-2030) 12.1.2 Global Long-acting Hormone Injection Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country (2025-2030) 12.3 APAC Forecast by Region (2025-2030) 12.4 Europe Forecast by Country (2025-2030) 12.5 Middle East & Africa Forecast by Country (2025-2030) 12.6 Global Long-acting Hormone Injection Forecast by Type (2025-2030) 12.7 Global Long-acting Hormone Injection Forecast by Application (2025-2030) 13 Key Players Analysis 13.1 Pfizer 13.1.1 Pfizer Company Information 13.1.2 Pfizer Long-acting Hormone Injection Product Portfolios and Specifications 13.1.3 Pfizer Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 Pfizer Main Business Overview 13.1.5 Pfizer Latest Developments 13.2 Bayer 13.2.1 Bayer Company Information 13.2.2 Bayer Long-acting Hormone Injection Product Portfolios and Specifications 13.2.3 Bayer Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 Bayer Main Business Overview 13.2.5 Bayer Latest Developments 13.3 Organon 13.3.1 Organon Company Information 13.3.2 Organon Long-acting Hormone Injection Product Portfolios and Specifications 13.3.3 Organon Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 Organon Main Business Overview 13.3.5 Organon Latest Developments 13.4 Merck & Co. Inc. 13.4.1 Merck & Co. Inc. Company Information 13.4.2 Merck & Co. Inc. Long-acting Hormone Injection Product Portfolios and Specifications 13.4.3 Merck & Co. Inc. Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 Merck & Co. Inc. Main Business Overview 13.4.5 Merck & Co. Inc. Latest Developments 13.5 Adare Pharma Solutions 13.5.1 Adare Pharma Solutions Company Information 13.5.2 Adare Pharma Solutions Long-acting Hormone Injection Product Portfolios and Specifications 13.5.3 Adare Pharma Solutions Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 Adare Pharma Solutions Main Business Overview 13.5.5 Adare Pharma Solutions Latest Developments 13.6 Mylan NV 13.6.1 Mylan NV Company Information 13.6.2 Mylan NV Long-acting Hormone Injection Product Portfolios and Specifications 13.6.3 Mylan NV Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 Mylan NV Main Business Overview 13.6.5 Mylan NV Latest Developments 13.7 Novo Nordisk 13.7.1 Novo Nordisk Company Information 13.7.2 Novo Nordisk Long-acting Hormone Injection Product Portfolios and Specifications 13.7.3 Novo Nordisk Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 Novo Nordisk Main Business Overview 13.7.5 Novo Nordisk Latest Developments 13.8 Genentech 13.8.1 Genentech Company Information 13.8.2 Genentech Long-acting Hormone Injection Product Portfolios and Specifications 13.8.3 Genentech Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 Genentech Main Business Overview 13.8.5 Genentech Latest Developments 13.9 Eli Lily 13.9.1 Eli Lily Company Information 13.9.2 Eli Lily Long-acting Hormone Injection Product Portfolios and Specifications 13.9.3 Eli Lily Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.9.4 Eli Lily Main Business Overview 13.9.5 Eli Lily Latest Developments 13.10 Shree Venkatesh International Limited 13.10.1 Shree Venkatesh International Limited Company Information 13.10.2 Shree Venkatesh International Limited Long-acting Hormone Injection Product Portfolios and Specifications 13.10.3 Shree Venkatesh International Limited Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.10.4 Shree Venkatesh International Limited Main Business Overview 13.10.5 Shree Venkatesh International Limited Latest Developments 13.11 LG Chem 13.11.1 LG Chem Company Information 13.11.2 LG Chem Long-acting Hormone Injection Product Portfolios and Specifications 13.11.3 LG Chem Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.11.4 LG Chem Main Business Overview 13.11.5 LG Chem Latest Developments 13.12 Anhui Anke Biotechnology 13.12.1 Anhui Anke Biotechnology Company Information 13.12.2 Anhui Anke Biotechnology Long-acting Hormone Injection Product Portfolios and Specifications 13.12.3 Anhui Anke Biotechnology Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.12.4 Anhui Anke Biotechnology Main Business Overview 13.12.5 Anhui Anke Biotechnology Latest Developments 13.13 Zhongshan Sinobioway Hygene Biomedicine 13.13.1 Zhongshan Sinobioway Hygene Biomedicine Company Information 13.13.2 Zhongshan Sinobioway Hygene Biomedicine Long-acting Hormone Injection Product Portfolios and Specifications 13.13.3 Zhongshan Sinobioway Hygene Biomedicine Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.13.4 Zhongshan Sinobioway Hygene Biomedicine Main Business Overview 13.13.5 Zhongshan Sinobioway Hygene Biomedicine Latest Developments 13.14 Shanghai United Cell Biotechnology 13.14.1 Shanghai United Cell Biotechnology Company Information 13.14.2 Shanghai United Cell Biotechnology Long-acting Hormone Injection Product Portfolios and Specifications 13.14.3 Shanghai United Cell Biotechnology Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.14.4 Shanghai United Cell Biotechnology Main Business Overview 13.14.5 Shanghai United Cell Biotechnology Latest Developments 13.15 Changchun GeneScience Pharmaceutical 13.15.1 Changchun GeneScience Pharmaceutical Company Information 13.15.2 Changchun GeneScience Pharmaceutical Long-acting Hormone Injection Product Portfolios and Specifications 13.15.3 Changchun GeneScience Pharmaceutical Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.15.4 Changchun GeneScience Pharmaceutical Main Business Overview 13.15.5 Changchun GeneScience Pharmaceutical Latest Developments 14 Research Findings and Conclusion
List of Tables Table 1. Long-acting Hormone Injection Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions) Table 2. Long-acting Hormone Injection Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions) Table 3. Major Players of Long-acting Contraceptive Injection Table 4. Major Players of Growth Hormone Injection Table 5. Major Players of Others Table 6. Global Long-acting Hormone Injection Sales by Type (2019-2024) & (K Units) Table 7. Global Long-acting Hormone Injection Sales Market Share by Type (2019-2024) Table 8. Global Long-acting Hormone Injection Revenue by Type (2019-2024) & ($ million) Table 9. Global Long-acting Hormone Injection Revenue Market Share by Type (2019-2024) Table 10. Global Long-acting Hormone Injection Sale Price by Type (2019-2024) & (US$/Unit) Table 11. Global Long-acting Hormone Injection Sale by Application (2019-2024) & (K Units) Table 12. Global Long-acting Hormone Injection Sale Market Share by Application (2019-2024) Table 13. Global Long-acting Hormone Injection Revenue by Application (2019-2024) & ($ million) Table 14. Global Long-acting Hormone Injection Revenue Market Share by Application (2019-2024) Table 15. Global Long-acting Hormone Injection Sale Price by Application (2019-2024) & (US$/Unit) Table 16. Global Long-acting Hormone Injection Sales by Company (2019-2024) & (K Units) Table 17. Global Long-acting Hormone Injection Sales Market Share by Company (2019-2024) Table 18. Global Long-acting Hormone Injection Revenue by Company (2019-2024) & ($ millions) Table 19. Global Long-acting Hormone Injection Revenue Market Share by Company (2019-2024) Table 20. Global Long-acting Hormone Injection Sale Price by Company (2019-2024) & (US$/Unit) Table 21. Key Manufacturers Long-acting Hormone Injection Producing Area Distribution and Sales Area Table 22. Players Long-acting Hormone Injection Products Offered Table 23. Long-acting Hormone Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) Table 24. New Products and Potential Entrants Table 25. Market M&A Activity & Strategy Table 26. Global Long-acting Hormone Injection Sales by Geographic Region (2019-2024) & (K Units) Table 27. Global Long-acting Hormone Injection Sales Market Share Geographic Region (2019-2024) Table 28. Global Long-acting Hormone Injection Revenue by Geographic Region (2019-2024) & ($ millions) Table 29. Global Long-acting Hormone Injection Revenue Market Share by Geographic Region (2019-2024) Table 30. Global Long-acting Hormone Injection Sales by Country/Region (2019-2024) & (K Units) Table 31. Global Long-acting Hormone Injection Sales Market Share by Country/Region (2019-2024) Table 32. Global Long-acting Hormone Injection Revenue by Country/Region (2019-2024) & ($ millions) Table 33. Global Long-acting Hormone Injection Revenue Market Share by Country/Region (2019-2024) Table 34. Americas Long-acting Hormone Injection Sales by Country (2019-2024) & (K Units) Table 35. Americas Long-acting Hormone Injection Sales Market Share by Country (2019-2024) Table 36. Americas Long-acting Hormone Injection Revenue by Country (2019-2024) & ($ millions) Table 37. Americas Long-acting Hormone Injection Sales by Type (2019-2024) & (K Units) Table 38. Americas Long-acting Hormone Injection Sales by Application (2019-2024) & (K Units) Table 39. APAC Long-acting Hormone Injection Sales by Region (2019-2024) & (K Units) Table 40. APAC Long-acting Hormone Injection Sales Market Share by Region (2019-2024) Table 41. APAC Long-acting Hormone Injection Revenue by Region (2019-2024) & ($ millions) Table 42. APAC Long-acting Hormone Injection Sales by Type (2019-2024) & (K Units) Table 43. APAC Long-acting Hormone Injection Sales by Application (2019-2024) & (K Units) Table 44. Europe Long-acting Hormone Injection Sales by Country (2019-2024) & (K Units) Table 45. Europe Long-acting Hormone Injection Revenue by Country (2019-2024) & ($ millions) Table 46. Europe Long-acting Hormone Injection Sales by Type (2019-2024) & (K Units) Table 47. Europe Long-acting Hormone Injection Sales by Application (2019-2024) & (K Units) Table 48. Middle East & Africa Long-acting Hormone Injection Sales by Country (2019-2024) & (K Units) Table 49. Middle East & Africa Long-acting Hormone Injection Revenue Market Share by Country (2019-2024) Table 50. Middle East & Africa Long-acting Hormone Injection Sales by Type (2019-2024) & (K Units) Table 51. Middle East & Africa Long-acting Hormone Injection Sales by Application (2019-2024) & (K Units) Table 52. Key Market Drivers & Growth Opportunities of Long-acting Hormone Injection Table 53. Key Market Challenges & Risks of Long-acting Hormone Injection Table 54. Key Industry Trends of Long-acting Hormone Injection Table 55. Long-acting Hormone Injection Raw Material Table 56. Key Suppliers of Raw Materials Table 57. Long-acting Hormone Injection Distributors List Table 58. Long-acting Hormone Injection Customer List Table 59. Global Long-acting Hormone Injection Sales Forecast by Region (2025-2030) & (K Units) Table 60. Global Long-acting Hormone Injection Revenue Forecast by Region (2025-2030) & ($ millions) Table 61. Americas Long-acting Hormone Injection Sales Forecast by Country (2025-2030) & (K Units) Table 62. Americas Long-acting Hormone Injection Annual Revenue Forecast by Country (2025-2030) & ($ millions) Table 63. APAC Long-acting Hormone Injection Sales Forecast by Region (2025-2030) & (K Units) Table 64. APAC Long-acting Hormone Injection Annual Revenue Forecast by Region (2025-2030) & ($ millions) Table 65. Europe Long-acting Hormone Injection Sales Forecast by Country (2025-2030) & (K Units) Table 66. Europe Long-acting Hormone Injection Revenue Forecast by Country (2025-2030) & ($ millions) Table 67. Middle East & Africa Long-acting Hormone Injection Sales Forecast by Country (2025-2030) & (K Units) Table 68. Middle East & Africa Long-acting Hormone Injection Revenue Forecast by Country (2025-2030) & ($ millions) Table 69. Global Long-acting Hormone Injection Sales Forecast by Type (2025-2030) & (K Units) Table 70. Global Long-acting Hormone Injection Revenue Forecast by Type (2025-2030) & ($ millions) Table 71. Global Long-acting Hormone Injection Sales Forecast by Application (2025-2030) & (K Units) Table 72. Global Long-acting Hormone Injection Revenue Forecast by Application (2025-2030) & ($ millions) Table 73. Pfizer Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors Table 74. Pfizer Long-acting Hormone Injection Product Portfolios and Specifications Table 75. Pfizer Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 76. Pfizer Main Business Table 77. Pfizer Latest Developments Table 78. Bayer Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors Table 79. Bayer Long-acting Hormone Injection Product Portfolios and Specifications Table 80. Bayer Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 81. Bayer Main Business Table 82. Bayer Latest Developments Table 83. Organon Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors Table 84. Organon Long-acting Hormone Injection Product Portfolios and Specifications Table 85. Organon Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 86. Organon Main Business Table 87. Organon Latest Developments Table 88. Merck & Co. Inc. Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors Table 89. Merck & Co. Inc. Long-acting Hormone Injection Product Portfolios and Specifications Table 90. Merck & Co. Inc. Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 91. Merck & Co. Inc. Main Business Table 92. Merck & Co. Inc. Latest Developments Table 93. Adare Pharma Solutions Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors Table 94. Adare Pharma Solutions Long-acting Hormone Injection Product Portfolios and Specifications Table 95. Adare Pharma Solutions Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 96. Adare Pharma Solutions Main Business Table 97. Adare Pharma Solutions Latest Developments Table 98. Mylan NV Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors Table 99. Mylan NV Long-acting Hormone Injection Product Portfolios and Specifications Table 100. Mylan NV Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 101. Mylan NV Main Business Table 102. Mylan NV Latest Developments Table 103. Novo Nordisk Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors Table 104. Novo Nordisk Long-acting Hormone Injection Product Portfolios and Specifications Table 105. Novo Nordisk Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 106. Novo Nordisk Main Business Table 107. Novo Nordisk Latest Developments Table 108. Genentech Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors Table 109. Genentech Long-acting Hormone Injection Product Portfolios and Specifications Table 110. Genentech Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 111. Genentech Main Business Table 112. Genentech Latest Developments Table 113. Eli Lily Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors Table 114. Eli Lily Long-acting Hormone Injection Product Portfolios and Specifications Table 115. Eli Lily Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 116. Eli Lily Main Business Table 117. Eli Lily Latest Developments Table 118. Shree Venkatesh International Limited Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors Table 119. Shree Venkatesh International Limited Long-acting Hormone Injection Product Portfolios and Specifications Table 120. Shree Venkatesh International Limited Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 121. Shree Venkatesh International Limited Main Business Table 122. Shree Venkatesh International Limited Latest Developments Table 123. LG Chem Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors Table 124. LG Chem Long-acting Hormone Injection Product Portfolios and Specifications Table 125. LG Chem Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 126. LG Chem Main Business Table 127. LG Chem Latest Developments Table 128. Anhui Anke Biotechnology Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors Table 129. Anhui Anke Biotechnology Long-acting Hormone Injection Product Portfolios and Specifications Table 130. Anhui Anke Biotechnology Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 131. Anhui Anke Biotechnology Main Business Table 132. Anhui Anke Biotechnology Latest Developments Table 133. Zhongshan Sinobioway Hygene Biomedicine Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors Table 134. Zhongshan Sinobioway Hygene Biomedicine Long-acting Hormone Injection Product Portfolios and Specifications Table 135. Zhongshan Sinobioway Hygene Biomedicine Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 136. Zhongshan Sinobioway Hygene Biomedicine Main Business Table 137. Zhongshan Sinobioway Hygene Biomedicine Latest Developments Table 138. Shanghai United Cell Biotechnology Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors Table 139. Shanghai United Cell Biotechnology Long-acting Hormone Injection Product Portfolios and Specifications Table 140. Shanghai United Cell Biotechnology Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 141. Shanghai United Cell Biotechnology Main Business Table 142. Shanghai United Cell Biotechnology Latest Developments Table 143. Changchun GeneScience Pharmaceutical Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors Table 144. Changchun GeneScience Pharmaceutical Long-acting Hormone Injection Product Portfolios and Specifications Table 145. Changchun GeneScience Pharmaceutical Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 146. Changchun GeneScience Pharmaceutical Main Business Table 147. Changchun GeneScience Pharmaceutical Latest Developments List of Figures Figure 1. Picture of Long-acting Hormone Injection Figure 2. Long-acting Hormone Injection Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Long-acting Hormone Injection Sales Growth Rate 2019-2030 (K Units) Figure 7. Global Long-acting Hormone Injection Revenue Growth Rate 2019-2030 ($ millions) Figure 8. Long-acting Hormone Injection Sales by Geographic Region (2019, 2023 & 2030) & ($ millions) Figure 9. Long-acting Hormone Injection Sales Market Share by Country/Region (2023) Figure 10. Long-acting Hormone Injection Sales Market Share by Country/Region (2019, 2023 & 2030) Figure 11. Product Picture of Long-acting Contraceptive Injection Figure 12. Product Picture of Growth Hormone Injection Figure 13. Product Picture of Others Figure 14. Global Long-acting Hormone Injection Sales Market Share by Type in 2023 Figure 15. Global Long-acting Hormone Injection Revenue Market Share by Type (2019-2024) Figure 16. Long-acting Hormone Injection Consumed in Hospital Figure 17. Global Long-acting Hormone Injection Market: Hospital (2019-2024) & (K Units) Figure 18. Long-acting Hormone Injection Consumed in Clinic Figure 19. Global Long-acting Hormone Injection Market: Clinic (2019-2024) & (K Units) Figure 20. Long-acting Hormone Injection Consumed in Others Figure 21. Global Long-acting Hormone Injection Market: Others (2019-2024) & (K Units) Figure 22. Global Long-acting Hormone Injection Sale Market Share by Application (2023) Figure 23. Global Long-acting Hormone Injection Revenue Market Share by Application in 2023 Figure 24. Long-acting Hormone Injection Sales by Company in 2023 (K Units) Figure 25. Global Long-acting Hormone Injection Sales Market Share by Company in 2023 Figure 26. Long-acting Hormone Injection Revenue by Company in 2023 ($ millions) Figure 27. Global Long-acting Hormone Injection Revenue Market Share by Company in 2023 Figure 28. Global Long-acting Hormone Injection Sales Market Share by Geographic Region (2019-2024) Figure 29. Global Long-acting Hormone Injection Revenue Market Share by Geographic Region in 2023 Figure 30. Americas Long-acting Hormone Injection Sales 2019-2024 (K Units) Figure 31. Americas Long-acting Hormone Injection Revenue 2019-2024 ($ millions) Figure 32. APAC Long-acting Hormone Injection Sales 2019-2024 (K Units) Figure 33. APAC Long-acting Hormone Injection Revenue 2019-2024 ($ millions) Figure 34. Europe Long-acting Hormone Injection Sales 2019-2024 (K Units) Figure 35. Europe Long-acting Hormone Injection Revenue 2019-2024 ($ millions) Figure 36. Middle East & Africa Long-acting Hormone Injection Sales 2019-2024 (K Units) Figure 37. Middle East & Africa Long-acting Hormone Injection Revenue 2019-2024 ($ millions) Figure 38. Americas Long-acting Hormone Injection Sales Market Share by Country in 2023 Figure 39. Americas Long-acting Hormone Injection Revenue Market Share by Country (2019-2024) Figure 40. Americas Long-acting Hormone Injection Sales Market Share by Type (2019-2024) Figure 41. Americas Long-acting Hormone Injection Sales Market Share by Application (2019-2024) Figure 42. United States Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions) Figure 43. Canada Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions) Figure 44. Mexico Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions) Figure 45. Brazil Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions) Figure 46. APAC Long-acting Hormone Injection Sales Market Share by Region in 2023 Figure 47. APAC Long-acting Hormone Injection Revenue Market Share by Region (2019-2024) Figure 48. APAC Long-acting Hormone Injection Sales Market Share by Type (2019-2024) Figure 49. APAC Long-acting Hormone Injection Sales Market Share by Application (2019-2024) Figure 50. China Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions) Figure 51. Japan Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions) Figure 52. South Korea Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions) Figure 53. Southeast Asia Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions) Figure 54. India Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions) Figure 55. Australia Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions) Figure 56. China Taiwan Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions) Figure 57. Europe Long-acting Hormone Injection Sales Market Share by Country in 2023 Figure 58. Europe Long-acting Hormone Injection Revenue Market Share by Country (2019-2024) Figure 59. Europe Long-acting Hormone Injection Sales Market Share by Type (2019-2024) Figure 60. Europe Long-acting Hormone Injection Sales Market Share by Application (2019-2024) Figure 61. Germany Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions) Figure 62. France Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions) Figure 63. UK Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions) Figure 64. Italy Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions) Figure 65. Russia Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions) Figure 66. Middle East & Africa Long-acting Hormone Injection Sales Market Share by Country (2019-2024) Figure 67. Middle East & Africa Long-acting Hormone Injection Sales Market Share by Type (2019-2024) Figure 68. Middle East & Africa Long-acting Hormone Injection Sales Market Share by Application (2019-2024) Figure 69. Egypt Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions) Figure 70. South Africa Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions) Figure 71. Israel Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions) Figure 72. Turkey Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions) Figure 73. GCC Countries Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions) Figure 74. Manufacturing Cost Structure Analysis of Long-acting Hormone Injection in 2023 Figure 75. Manufacturing Process Analysis of Long-acting Hormone Injection Figure 76. Industry Chain Structure of Long-acting Hormone Injection Figure 77. Channels of Distribution Figure 78. Global Long-acting Hormone Injection Sales Market Forecast by Region (2025-2030) Figure 79. Global Long-acting Hormone Injection Revenue Market Share Forecast by Region (2025-2030) Figure 80. Global Long-acting Hormone Injection Sales Market Share Forecast by Type (2025-2030) Figure 81. Global Long-acting Hormone Injection Revenue Market Share Forecast by Type (2025-2030) Figure 82. Global Long-acting Hormone Injection Sales Market Share Forecast by Application (2025-2030) Figure 83. Global Long-acting Hormone Injection Revenue Market Share Forecast by Application (2025-2030)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
"Pfizer"|||"Bayer"|||"Organon"|||"Merck & Co. Inc."|||"Adare Pharma Solutions"|||"Mylan NV"|||"Novo Nordisk"|||"Genentech"|||"Eli Lily"|||"Shree Venkatesh International Limited"|||"LG Chem"|||"Anhui Anke Biotechnology"|||"Zhongshan Sinobioway Hygene Biomedicine"|||"Shanghai United Cell Biotechnology"|||"Changchun GeneScience Pharmaceutical"